Impairment of contrast visual acuity as a functional correlate of retinal nerve fibre layer thinning and total macular volume reduction in multiple sclerosis

British Journal of Ophthalmology

Volumn 96, Issue 1, 2012, Pages 62-67

  Bock, Markus ^a   Brandt, Alexander U ^a,b   Kuchenbecker, Jörn ^c   Dörr, Jan ^a   Pfueller, Caspar F ^a   Weinges Evers, Nicholetta ^a   Gaede, Gunnar ^a   Zimmermann, Hanna ^a   Bellmann Strobl, Judith ^a   Ohlraun, Stephanie ^a   Zipp, Frauke ^a,d   Paul, Friedemann ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b gfnmediber GmbH   (Germany)

^c HELIOS KLINIKUM BERLIN BUCH   (Germany)

^d UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AREA UNDER THE CURVE; ARTICLE; CONTRAST SENSITIVITY; CONTROLLED STUDY; DISEASE ASSOCIATION; EYE EXAMINATION; FEASIBILITY STUDY; FEMALE; FUNCTIONAL ACUITY CONTRAST TESTING; FUNCTIONAL MORPHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; OPTICAL COHERENCE TOMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; RETINAL NERVE FIBER LAYER THICKNESS; TOTAL MACULAR VOLUME; VISUAL ACUITY; VISUAL IMPAIRMENT; VISUAL SYSTEM PARAMETERS;

ADULT; CONTRAST SENSITIVITY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LINEAR MODELS; MACULA LUTEA; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NERVE FIBERS; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, OPTICAL COHERENCE; VISION DISORDERS; VISUAL ACUITY; YOUNG ADULT;

EID: 84455195434     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2010.193581     Document Type: Article

References (35)

1. Compston A, Coles A. Multiple sclerosis. Lancet 2008;372:1502-17.
2. Beck RW, Cleary PA. Optic neuritis treatment trial. One-year follow-up results. Arch Ophthalmol 1993;111:773-5. (Pubitemid 23170588)
3. Balcer LJ, Baier ML, Cohen JA, et al. Contrast letter acuity as a visual component for the Multiple Sclerosis Functional Composite. Neurology 2003;61:1367-73. (Pubitemid 37463372)
4. Rudick RA, Miller D, Clough JD, et al. Quality of life in multiple sclerosis. Comparison with inflammatory bowel disease and rheumatoid arthritis. Arch Neurol 1992;49:1237-42.
5. Regan D, Raymond J, Ginsburg AP, et al. Contrast sensitivity, visual acuity and the discrimination of Snellen letters in multiple sclerosis. Brain 1981;104:333-50. (Pubitemid 12183325)
6. Mowry EM, Loguidice MJ, Daniels AB, et al. Vision related quality of life in multiple sclerosis: correlation with new measures of low and high contrast letter acuity. J Neurol Neurosurg Psychiatry 2009;80:767-72.
7. Baier ML, Cutter GR, Rudick RA, et al. Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis. Neurology 2005;64:992-5. (Pubitemid 40388449)
8. Kupersmith MJ, Nelson JI, Seiple WH, et al. The 20/20 eye in multiple sclerosis. Neurology 1983;33:1015-20. (Pubitemid 13030182)
9. Barkhof F, Calabresi PA, Miller DH, et al. Imaging outcomes for neuroprotection and repair in multiple sclerosis trials. Nat Rev Neurol 2009;5:256-66.
10. Frohman E, Costello F, Zivadinov R, et al. Optical coherence tomography in multiple sclerosis. Lancet Neurol 2006;5:853-63. (Pubitemid 44715820)
11. Naismith RT, Tutlam NT, Xu J, et al. Optical coherence tomography is less sensitive than visual evoked potentials in optic neuritis. Neurology 2009;73:46-52.
12. Fisher JB, Jacobs DA, Markowitz CE, et al. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology 2006;113:324-32. (Pubitemid 43170783)
13. Merle H, Olindo S, Donnio A, et al. Retinal nerve fiber layer thickness and spatial and temporal contrast sensitivity in multiple sclerosis. Eur J Ophthalmol 2010;20:158-66.
14. Bühren J, Terzi E, Bach M, et al. Measuring contrast sensitivity under different lighting conditions: comparison of three tests. Optom Vis Sci 2006;83:290-8. (Pubitemid 43804567)
15. Ginsburg AP. Contrast sensitivity: determining the visual quality and function of cataract, intraocular lenses and refractive surgery. Curr Opin Ophthalmol 2006;17:19-26. (Pubitemid 43035633)
16. Applegate R, Hilmantel G, Howland H. Area under the log contrast sensitivity function: A concise method of following changes in visual performance. OSA Technical Digest Series 1997;1:98-101.
17. Applegate RA, Howland HC, Sharp RP, et al. Corneal aberrations and visual performance after radial keratotomy. J Refract Surg 1998;14:397-407. (Pubitemid 28350703)
18. Hohberger B, Laemmer R, Adler W, et al. Measuring contrast sensitivity in normal subjects with OPTEC 6500: influence of age and glare. Graefes Arch Clin Exp Ophthalmol 2007;245:1805-14. (Pubitemid 350154015)
19. Hiraoka T, Okamoto C, Ishii Y, et al. Recovery of corneal irregular astigmatism, ocular higher-order aberrations, and contrast sensitivity after discontinuation of overnight orthokeratology. Br J Ophthalmol 2009;93:203-8.
20. Oshika T, Okamoto C, Samejima T, et al. Contrast sensitivity function and ocular higher-order wavefront aberrations in normal human eyes. Ophthalmology 2006;113:1807-12. (Pubitemid 44442434)
21. Yamane N, Miyata K, Samejima T, et al. Ocular higher-order aberrations and contrast sensitivity after conventional laser in situ keratomileusis. Invest Ophthalmol Vis Sci 2004;45:3986-90. (Pubitemid 39411151)
22. Marcos S. Aberrations and visual performance following standard laser vision correction. J Refract Surg 2001;17:S596-601. (Pubitemid 32896395)
23. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the 'McDonald Criteria.' Ann Neurol 2005;58:840-6. (Pubitemid 41746873)
24. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-52. (Pubitemid 14237132)
25. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing, 2010. http://www.R-project.org.
26. Petzold A, de Boer JF, Schippling S, et al. Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol 2010;9:921-32.
27. Balcer LJ, Baier ML, Kunkle AM, et al. Self-reported visual dysfunction in multiple sclerosis: results from the 25-Item National Eye Institute Visual Function Questionnaire (VFQ-25). Mult Scler 2000;6:382-5. (Pubitemid 32106798)
28. Hong YT, Kim SW, Kim EK, et al. Contrast sensitivity measurement with 2 contrast sensitivity tests in normal eyes and eyes with cataract. J Cataract Refract Surg 2010;36:547-52.
29. Arditi A. Improving the design of the letter contrast sensitivity test. Invest Ophthalmol Vis Sci 2005;46:2225-9.
30. Thayaparan K, Crossland MD, Rubin GS. Clinical assessment of two new contrast sensitivity charts. Br J Ophthalmol 2007;91:749-52. (Pubitemid 46846644)
31. Pesudovs K, Marsack JD, Donnelly WJ, et al. Measuring visual acuity-mesopic or photopic conditions, and high or low contrast letters? J Refract Surg 2004;20: S508-14. (Pubitemid 39299551)
32. Ginsburg AP. Contrast sensitivity and functional vision. Int Ophthalmol Clin 2003;43:5-15. (Pubitemid 36459065)
33. Leguire LE. Do letter charts measure contrast sensitivity? Clin Vision Sci 1991;6:391-400.
34. Ginsburg AP, Cannon MW. Comments on variability in contrast sensitivity methodology. Vision Res 1984;24:287.
35. Reeves BC, Hill AR, Ross JE. Testeretest reliability of the Arden Grating Test: inter-tester variability. Ophthalmic Physiol Opt 1988;8:128-38.